Pharmaceutical Peptide In Stock

Lixisenatide

A short-acting GLP-1 receptor agonist derived from exendin-4, with a 4-hour half-life in humans, designed for prandial glucose control

Tags: Short-acting GLP-1 agonist Exendin-4 derived Prandial glucose control

FDA Compliant

cGMP Certified

Pharmaceutical Grade

Sample Policy

Free Sample / Freight Charged / to final agreement

Expert Support

Pharmaceutical Team

CAS Number

851861-62-6

Purity (HPLC)

≥99.0%

Molecular Formula (MF)

C215H347N61O65S

Molecular Weight (MS)

3947.18 g/mol

Adjunct to diet and exercise for type 2 diabetes mellitus to improve glycemic control

Parameter	Specification
CAS Number	851861-62-6
Molecular Formula (MF)	C215H347N61O65S
Molecular Weight (MS)	3947.18 g/mol
Purity (HPLC)	≥99.0%
Sequence	H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
Packaging	1g-1kg, plastic bottle
Appearance	White powder
Storage temp.	Store at 2-8 degrees Celsius in a dry and cool place.

Related Peptides

Contact our pharmaceutical team for custom peptide synthesis, bulk orders, and technical support for your drug development needs.